Top 50 Medical Device Startup Investors in Switzerland (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Zürcher Kantonal Bank
VC Fund
|
24 | Switzerland, Germany, Japan | Seed, Series A | Health Care, Biotechnology, Medical Device | $1.2M–$13M |
|
Foundation for Innovation and Technology (FIT)
VC Fund
|
15 | Switzerland, France, United States | Debt Financing, Grant, Seed | Health Care, Biotechnology, Artificial Intelligence | $13k–$1.2M |
|
Verve Ventures
VC Fund
|
13 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $1.4M–$45M |
|
VI Partners
VC Fund
|
9 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
StartAngels Network
VC Fund
|
7 | Switzerland, Brazil | Seed, Series A, Series B | Medical, Health Care, Medical Device | $933k–$6.1M |
|
4FOX Ventures
VC Fund
|
6 | Switzerland | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.1M–$69M |
|
BioMedPartners
VC Fund
|
5 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.9M–$83M |
|
OCCIDENT
VC Fund
|
5 | Switzerland, Germany, Finland | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $874k–$139M |
|
redalpine
VC Fund
|
5 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.6M–$60M |
|
Kickfund
VC Fund
|
5 | Switzerland, Germany | Seed, Pre-Seed, Convertible Note | Biotechnology, Manufacturing, Medical | $110k–$5.7M |
|
Zühlke Ventures AG
VC Fund
|
4 | Switzerland, Sweden, United States | Series A, Seed, Series B | Health Care, Medical Device, Medical | $1.2M–$11M |
|
Innosuisse
VC Fund
|
4 | Switzerland, United States, United Kingdom | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Medical Device | $17k–$16M |
|
Translink Capital
VC Fund
|
4 | United States, China, South Korea | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $4M–$58M |
|
EVA Basel
VC Fund
|
3 | Switzerland | Seed, Series A | Biotechnology, Medical Device, Medical | $1.9M–$3.6M |
|
VitaTech S.A
VC Fund
|
3 | Switzerland, United States | Series A | Biotechnology, Medical Device, Therapeutics | |
|
Neomed Management
VC Fund
|
3 | Switzerland, United States, Italy | Series B, Series C | Health Care, Biotechnology, Medical | $10M–$65M |
|
Fongit Seed Invest
VC Fund
|
3 | Switzerland | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $1.2M–$3.7M |
|
415 Capital
VC Fund
|
3 | Switzerland, United States, France | Series A, Series B, Series C | Medical Device, Health Care, Medical | $5.2M–$87M |
|
Alpana Ventures
VC Fund
|
3 | United States, Switzerland, Germany | Seed, Series A | Software, FinTech, Information Technology | $850k–$14M |
|
3wVentures
VC Fund
|
3 | Switzerland, Spain, Austria | Seed, Angel, Series A | Software, Health Care, Medical | $50k–$8M |
|
M Ventures
VC Fund
|
3 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
SICTIC
VC Fund
|
3 | Switzerland, Germany, Tanzania | Seed, Pre-Seed | Software, Artificial Intelligence, Information Technology | $302k–$3M |
|
BlueOcean Ventures
VC Fund
|
3 | Switzerland, India, France | Seed, Series A, Series B | Health Care, Medical, Personal Health | $1M–$20M |
|
EIT Health
VC Fund
|
3 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $22k–$1.6M |
|
S2S Ventures
VC Fund
|
3 | Switzerland, Germany | Pre-Seed, Seed | Health Care, Artificial Intelligence, Manufacturing | $28k–$3.4M |
|
Polytech Ventures
VC Fund
|
2 | Switzerland, United States, Spain | Seed, Series A | Financial Services, FinTech, Software | $1M–$9.7M |
|
TiVentures
VC Fund
|
2 | Switzerland, Italy, United States | Seed, Series A | Software, Analytics, SaaS | $583k–$3.3M |
|
New Enterprise Associates
VC Fund
|
2 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.4M–$103M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $500k–$43M |
|
Swisscom Ventures
VC Fund
|
2 | Switzerland, United States, United Kingdom | Series B, Series A | Software, SaaS, Information Technology | $1.8M–$60M |
|
Ecosystem Ventures
VC Fund
|
2 | United States, India, Switzerland | Seed, Series A | Mobile Apps, Mobile, Finance | $203k–$15M |
|
Inkef
VC Fund
|
2 | The Netherlands, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2.8M–$86M |
|
Schroder Adveq
VC Fund
|
2 | Switzerland, United States, India | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $5.6M–$100M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
CADFEM
VC Fund
|
2 | Switzerland | Seed, Convertible Note | Medical Device, Medical, Construction | $2.7M–$3.8M |
|
M2care
VC Fund
|
2 | France, Switzerland | Seed | Medical, Hospital, Health Care | $1.1M–$2.9M |
|
Christian Wenger
Angel
|
2 | Switzerland, Germany, Australia | Seed, Series A | SaaS, Internet, Software | $800k–$6.8M |
|
Evercurious VC
VC Fund
|
2 | Switzerland, Belgium, Germany | Seed, Pre-Seed, Series A | Health Care, Medical, Chemical | $1.2M–$7.7M |
|
Athanasios Papagelis
Angel
|
2 | Switzerland, United Kingdom | Seed, Pre-Seed | EdTech, Medical, Software | |
|
Molten Ventures
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Series B | Software, Information Technology, Financial Services | $3.2M–$60M |
|
Dominik A. Lysek
Angel
|
2 | Switzerland | Seed | Wellness, Health Care, Medical Device | $1.1M–$2.9M |
|
Initiative Capital Romandie
VC Fund
|
2 | Switzerland | Series A, Series B, Series E | Health Care, Biotechnology, Medical Device | $6.8M–$10M |
|
Privilège Ventures
VC Fund
|
1 | Switzerland, France | Seed, Series A | Health Care, Hardware, Software | |
|
European Commission
VC Fund
|
1 | Spain, France, Germany | Grant, Seed, Pre-Seed | Software, Biotechnology, Health Care | |
|
NEST pension fund
VC Fund
|
1 | Switzerland | Seed, Series A | Health Care, Biotechnology, Medical | |
|
Steyn Group
VC Fund
|
1 | United Kingdom, Switzerland, South Africa | Seed, Series A, Series B | Advice, Hospital, CleanTech | |
|
Clement Benoit
Angel
|
1 | France, United States, Spain | Seed, Series A, Pre-Seed | Software, E-Commerce, FinTech | |
|
SHS Capital
VC Fund
|
1 | Germany, Switzerland, France | Series C, Series A | Health Care, Medical Device, Medical | |
|
Supermoon Capital
VC Fund
|
1 | Switzerland, United States, Israel | Seed, Series A | Health Care, Artificial Intelligence, Medical Device | |
|
AA Sons
VC Fund
|
1 | France, United States, Israel | Seed, Series A | Software, Information Technology, E-Commerce | |
| Access all 335 investors in Switzerland Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Switzerland, Germany, Japan
Investor stats
- Total investments: 195
- Round size: Seed $1.2M–$6M; Series A $2.3M–$13M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
- Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France, United States
Investor stats
- Total investments: 196
- Round size: Seed $117k–$1.2M; Grant $13k–$125k; Debt Financing $107k–$583k
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- MyStones — MyStones turns athlete health and performance data into actionable insights, preventing injuries and strengthening collaboration between athletes, coaches, and physiotherapists.
- Skilder Ai — skilder is an Agent Skills Management Platform that organizes and governs how teams use AI assistants like Claude, ChatGPT, and Microsoft Copilot.
- Isospec Analytics — Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are unlocking the potential of glycomics and metabolomics in disease biomarker discovery and for the development of safer nutritional and pharmaceutical products.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 273
- Round size: Seed $1.4M–$12M; Series A $2.6M–$18M; Series B $4.2M–$45M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $66M in 2022
Portfolio highlights
- Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
- Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
- Clinpal — Backed by over 30 years of scientific discovery and validation, Cambridge Cognition offers the end-to-end platform for CNS clinical trials.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 111
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Equippo.com — Used construction equipment marketplace. Easy and safe. Only inspected machines. Worldwide delivery. Money Back Guaranteed. Buy Now, Pay Later!
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Brazil
Investor stats
- Total investments: 28
- Round size: Seed $933k–$3.4M; Series A $2.1M–$3.7M; Series B $1.7M–$6.1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Rflect — Rflect helps universities protect their business model in the age of AI by training the human skills machines cannot replace—reflection, resilience, collaboration—directly inside the curriculum for credit. As AI commoditizes knowledge and devalues degrees, Rflect secures degree value through measurable human development and audit-ready data foraccreditation, employability, and retention. Embedded as credit-bearing infrastructure, Rflect achieves 100% student usage, zero institutional churn, and long-term lock-in cycles.
- Calingo — Calingo is a digital insurance platform that offers personalised and optimised risk protection at the point of sale.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
4FO Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland
Investor stats
- Total investments: 20
- Round size: Seed $2.1M–$3.6M; Series A $2.1M–$15M; Series B $6.4M–$69M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
- Neo Medical — Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 87
- Round size: Series A $5.5M–$31M; Series B $4.9M–$83M; Series C $5.8M–$48M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $113M in 2018
Portfolio highlights
- T-CURX — T-CURX is a biotechnology company focused on the development of personalized cancer immunotherapies. Utilizing a proprietary platform, T-CURX aims to advance the field of T cell therapies to address the challenges faced in treating various cancers. The company's innovative approach involves the creation of a new generation of T cells designedto improve patient outcomes. As a spin-out from the University Clinics Würzburg, Germany, T-CURX leverages the expertise of its co-founders, including Prof. Michael Hudecek, to pioneer in the area of CAR-T cell-based medicines. With a commitment to transforming cancer treatment, T-CURX is at the forefront of developing targeted therapies that offer hope for a more effective and personalized approach to cancer care.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, Finland
Investor stats
- Total investments: 33
- Round size: Seed $874k–$5.2M; Series A $2.1M–$16M; Series B $6.2M–$139M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- Lunaphore — Lunaphore Technologies is a spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 191
- Round size: Seed $1.6M–$13M; Series A $3.2M–$31M; Series B $15M–$60M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $25M in 2013
Portfolio highlights
- 9fin — The leading AI-powered debt market intelligence platform. Real-time news, data, and analytics across LevFin, private credit, and distressed debt.
- Luya Foods — Sustainable food, Plant-based, Circular food, Meat alternative, Alternative to meat, Okara, Food waste, and Fermentation
- Carvolution — Carvolution is the next-generation mobility services provider reshaping car ownership through its fully digital subscription service.Carvolution makes choosing a new car exciting. As it removes the hassle out of ownership and the inflexibility out of leasing, it enables consumers to choose their dream car as a convenient monthly subscriptionservice instead of a long-term commitment. Their digitally-powered one-stop-shop streamlines everything from insurance to maintenance: saving customers time and money while enabling efficiencies for all connected parties.
Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Switzerland, Germany
Investor stats
- Total investments: 47
- Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4.4M; Convertible Note $110k–$118k
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- SolidWatts — We electrify industrial process heating by creating the new state-of-the-art in microwave and radio frequency power sources for industry.
- Cosaic — Cultivated - Creamy, dairy-free indulgence
- BLEEDnFIRE Therapeutics — BLEEDnFIRE Therapeutics: At BLEEDnFIRE Therapeutics, we are pioneering innovative siRNA-based therapies for hemophilia, Von Willebrand disease & other rare bleeding disorders (RBDs) by developing BnF-001. Our mission is to transform patient care and improve quand improve quality of life through targeted ...
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Sweden, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.2M–$3M; Series A $7M–$11M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Evismo — Diagnosing arrhythmias, sleep apnea, and stress directly in your practice. Digitally and efficiently. For general practitioners and specialists in Switzerland.
- Healios AG — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
- PeriVision — At Perivision, we combine artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to understand visual function. Our systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Pre-Seed, Seed
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 234
- Round size: Seed $500k–$16M; Grant $30k–$2.5M; Pre-Seed $17k–$4.3M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- OrthoSens — OrthoSens develops battery-free sensors that turn standard orthopedic implants into smart, data-driven devices. Unlike existing smart implant solutions that require an implanted battery making them too large and too risky to scale beyond large joints, OrthoSens moves all electronics outside the body. A paper-thin sensor integrates directly intoexisting implants with no battery, no surgical workflow change and zero explant risk. An external wearable powers the sensor wirelessly and collects real-time data on load, micromotion and bone fusion. The result is a footprint 250x smaller than battery-powered competitors, opening up additional spine, foot & ankle markets that existing solutions cannot address. The clinical need is clear: approximately 20% of post-surgical patients drive around 68% of total post-operative costs through missed complications, continuous implant monitoring exists to catch them earlier. Starting January 2026, 745 US hospitals enrolled in CMS's mandatory TEAM bundle are now accountable for 30-day episode costs, creating direct institutional demand for this data.OrthoSens generates revenue through three streams: sensor sales to orthopedic implant manufacturers (unlocking +$1,309 NTAP reimbursement per unit), a SaaS subscription capturing 40% of Medicare's $104/month RPM reimbursement per patient and post-market data analytics. The company has validated its technology across 3 functional prototypes, filed 2 core patents with favorable Freedom to Operate and secured $1.3M+ in non-dilutive funding. It is raising a $2.3M seed round to complete ISO-13485 certification, conduct the FDA pre-clinical study and file a 510(k) submission. The team is led by Gwenael Hannema (3x medtech founder), Dr. Oleg Kotsur (Head of R&D), and key employees, supported by experienced board members with leadership backgrounds at Novartis, Medtronic and J&J MedTech.
- Precise Health — Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to end the threat of antimicrobial resistance through an AI-powered technology.
- BLEEDnFIRE Therapeutics — BLEEDnFIRE Therapeutics: At BLEEDnFIRE Therapeutics, we are pioneering innovative siRNA-based therapies for hemophilia, Von Willebrand disease & other rare bleeding disorders (RBDs) by developing BnF-001. Our mission is to transform patient care and improve quand improve quality of life through targeted ...
Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, China, South Korea
Investor stats
- Total investments: 163
- Round size: Series A $4M–$27M; Series B $9.9M–$42M; Series C $10M–$58M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Luxul Technology — Awoken by environmental concerns and dreams to shine the world, Luxul Technology Inc. was established in 2010 in Santa Clara, California, to provide customers with high quality LED lamps to save energy bill and installation cost.Our EazyLux T5 and T8 LED Lamps are the world’s first LED tube lights that are fully compatible with existingfluorescent lamps using E-ballasts. Through our devoted efforts, we have made this dream come true: long life LED lamps that are extremely easy to install while reducing your energy bill by 50%. Founded by James Pan, Ph.D. of Stanford University, our research and development teams in the US and Taiwan consists of the most dedicated engineers from all disciplines: such as electrical, optical, mechanical, software, graphic and art designs. Backed by more than 50 worldwide patents, our goal is to apply world class technologies to lighting products that benefits everyone’s life while conserving our environment. Luxul’s products represent Quality, Beauty and Simplicity.With increasing demand in the US and Mexico, we are expanding our manufacturing facilities and sales offices in the US and Mexico.
- Adwo Media Holdings Develops mobile advertising platform best mobile marketing services — Beijing Adwo Mobile Media Technology Ltd. develops mobile advertising platform. The company was founded in 2010 and is based in Beijing, China.
- Winking Entertainment — Headquartered in Singapore. Winking Studios is one of the largest game art outsourcing and game development studios globally.
EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 4
- Round size: Seed $1.9M–$3.6M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AOT - Advanced Osteotomy Tools — AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser,robotics and navigation systems to re-invent bone surgery (osteotomy).
- POLYNEURON — Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patientswith immune disorders in a safe and effective manner.
- Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
VitaTech S.A
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Therapeutics
- Stage:Series A
- Geography: Switzerland, United States
Investor stats
- Total investments: 4
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
- Gain Therapeutics — Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
- Industrie Biomediche Insubri — IBI is an innovative hi-tech Swiss biomedical company focused on research, development and production of medical devices for tissue engineering and regenerative medicine: substitutes, grafts, 3D matrixes and 2D scaffolds.
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C
- Geography: Switzerland, United States, Italy
Investor stats
- Total investments: 40
- Round size: Series B $20M–$65M; Series C $10M–$44M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Switzerland
Investor stats
- Total investments: 9
- Round size: Seed $1.2M–$1.4M; Series A $2.3M–$3.7M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
- Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
- Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcaresystem.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 16
- Round size: Series A $5.2M–$31M; Series B $35M–$87M; Series C $30M–$80M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Seed, Series A
- Geography: United States, Switzerland, Germany
Investor stats
- Total investments: 98
- Round size: Seed $850k–$4M; Series A $2.3M–$14M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
- Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
- Tinamu — Trusted inventory intelligence delivered in real-time
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: Switzerland, Spain, Austria
Investor stats
- Total investments: 42
- Round size: Seed $50k–$3.8M; Angel $583k–$2.1M; Series A $1.2M–$8M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — raised $100M in 1999
Portfolio highlights
- Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
- GUURU Solutions — Discover how community-powered advice can turn your PDPs into trusted, high-converting content and get cited in AI search.
- Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 171
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- Future Fertility — OUR AI-POWERED ASSESSMENTS GUIDE PERSONALIZED FERTILITY TREATMENT DECISIONS IN OVER 180 CLINICS ACROSS 32 COUNTRIES
- ApoGen Biotechnologies — ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapieseventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany, Tanzania
Investor stats
- Total investments: 210
- Round size: Seed $583k–$3M; Pre-Seed $302k–$2.1M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Agrinorm — Agrinorm is a Swiss deep tech company leveraging cutting edge machine learning techniques for the optimization of fruits and veg supply chains.
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- Get More Brain — Digital learning platform connecting learners and their employers with teachers and schools, publishers and EdTech companies. Marketplace for learning content and learning related services.
BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.
Show more...Investment focus
- Industry: Health Care, Medical, Personal Health
- Stage:Seed, Series A, Series B
- Geography: Switzerland, India, France
Investor stats
- Total investments: 17
- Round size: Seed $1M–$3M; Series A $2.3M–$20M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Augurix — Just another WordPress site
- Mikajaki — Mikajaki is an innovative automated multi-patient ocular diagnostics platform. The platform enables the use of digital technology, robots, AI, and data, allowing patients and eye specialists access to the specific treatment they require. Mikajaki is currently collaborating with ophthalmology clinic groups across the world to test and implementEyeLib.
- official.fm — At Official.fm, they develop powerful music promotion tools for you, whether you're an emerging artist or an accomplished label.They make it easy to manage a few tracks or a large catalog, create pages and players that look like you and share them across your favorite promotion platforms and social networks, all the while collectinginsightful analytics. Improving your workflow is their top priority.Promoting your music with official.fm will always be free. Music promotion is an investment for you and it is one for us too. Now you also have the ability to sell directly music to your fans. Soon they will offer more ways for your to generate revenue from your music.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 97
- Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Manufacturing
- Stage:Pre-Seed, Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 27
- Round size: Seed $954k–$3.4M; Pre-Seed $28k–$2.9M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $13M in 2021
Portfolio highlights
- Haicker — Haicker is an AI-driven cybersecurity platform designed to automatically detect vulnerabilities in web application codebases with exceptional precision. Leveraging advanced Large Language Model (LLM)-based agents, Haicker outperforms traditional security testing solutions by removing false positives and providing actionable insights that helpdevelopers fix vulnerabilities swiftly and confidently.Traditional static (SAST) and dynamic (DAST) application security testing tools typically suffer from high rates of false positives, demanding significant manual review efforts from developers and security teams. Haicker addresses this core challenge through its unique architecture: all issues are validated against a replica of the application, allowing Haicker to filter real findings from hallucinations.Initially proven in competitive cybersecurity environments like Capture-the-Flag (CTF) competitions, Haicker quickly demonstrated superior performance and reliability on open source projects. Its capabilities extend beyond vulnerability scanning, integrating seamlessly into common development workflows, including continuous integration and delivery pipelines.Haicker's scalable architecture ensures enhanced performance as computational resources and AI models evolve and become more cost-effective. By leveraging a distributed approach where multiple AI agents concurrently analyze the same piece of code, Haicker ensures comprehensive vulnerability detection with unprecedented depth and efficiency.Targeted at security-conscious enterprises, software development teams, and DevSecOps practitioners, Haicker empowers organizations to shift security left, integrating deep vulnerability detection early into the development lifecycle. Its intuitive interface and streamlined integration capabilities with leading code management platforms such as GitHub, GitLab, and Bitbucket enable effortless adoption.Founded in Switzerland by cybersecurity and web development experts, Haicker is positioned to transform the application security market by offering a smarter, faster, and more reliable alternative to manual penetration tests and legacy automated scanning solutions.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
- Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: Switzerland, United States, Spain
Investor stats
- Total investments: 50
- Round size: Seed $1M–$5M; Series A $2.3M–$9.7M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
- Hemostod — Developing universal platelets and next-generation diagnostics
- Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more...Investment focus
- Industry: Software, Analytics, SaaS
- Stage:Seed, Series A
- Geography: Switzerland, Italy, United States
Investor stats
- Total investments: 23
- Round size: Seed $583k–$2M; Series A $1.9M–$3.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- InkVivo — InkVivo provides clinicians and healthcare providers with a product delivery system that optimizes treatments. Their manufacturing approach allows users to design implantable patches, tablets, and injectable biomaterials.
- Artificialy — Artificialy provides custom AI solutions, consulting, and training for enterprises in Switzerland and beyond. Artificial Intelligence actually delivered.
- Jaipur Robotics — Jaipur Robotics focuses on developing AI software for waste recycling ecosystem.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1581
- Round size: Series A $5.4M–$60M; Series B $10M–$77M; Series C $14M–$103M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $2.8B in 2022
Portfolio highlights
- IonQ — Working to build the world's best quantum computers to solve the world's most complex problems
- Spyglass Ophthalmics — A vision towards a higher quality of life!
- Xenon Pharmaceuticals — A leading neuroscience company forging new paths for those living with neurological and psychiatric disorders.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 133
- Round size: Seed $500k–$11M; Series A $2M–$43M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series B, Series A
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 143
- Round size: Series A $1.8M–$23M; Series B $2.3M–$60M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
- Billogram — Since its start in 2011, Billogram has revitalized the outdated invoicing process by offering companies with recurring payments an intelligent digital platform. Using smart technology, we help companies strengthen their customer relations while also automating payment processes in a way that lowers costs, increases revenue, and reduces churn. Theresult is a payment that pays off for everyone.
- Bring! Labs — Bring! Labs is an app for multi-device use that accompanies the user through all aspects of shopping for groceries and other everyday items. It offers grocery shopping for millions of people with shared shopping lists, integrated recipes, online shopping, local offers, and loyalty cards. Bring! Labs offers innovative mobile advertising platforms tocompanies in the retail and FMCG.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ecosystem Ventures, a Silicon Valley-based venture capital, offers investment and strategic consulting services to seed-stage companies.
Show more...Investment focus
- Industry: Mobile Apps, Mobile, Finance
- Stage:Seed, Series A
- Geography: United States, India, Switzerland
Investor stats
- Total investments: 27
- Round size: Seed $203k–$2M; Series A $700k–$15M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- GeoIQ.io — ML-ready location data and no-code AI for fintech
- SpeEdLabs — SpeEdLabs is to provide a top-notch, technology-based Learning and Practice platform to students at an affordable price, thus empowering every student to grow into their full potential.
- Mindler — Discover your perfect career, stream, college & course with India's leading career counsellors. Career counselling & guidance programs for school, college students & graduates.
SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: The Netherlands, United States, Germany
Investor stats
- Total investments: 87
- Round size: Seed $2.8M–$21M; Series A $3.2M–$42M; Series B $8.2M–$86M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $585M in 2016
Portfolio highlights
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- Cardior Pharmaceuticals — Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: Switzerland, United States, India
Investor stats
- Total investments: 36
- Round size: Series A $5.6M–$23M; Series B $11M–$83M; Series C $15M–$100M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — raised $113M in 2020
Portfolio highlights
- Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
CADFEM provides engineering analysis software sales, consultancy, training and technical services to a variety of global and UK customers.These products provide engineers with broad, high end analysis functionality for the development of leading edge products and state of the art manufacturing processes. Cumulatively our group of 18 skilled andmotivated staff have more than 100 years experience in providing and supporting simulation led engineering solutions. Our expertise is spread across a wide range of engineering sectors: medical devices, renewable energy, aerospace, automotive, civil engineering, mechanical engineering, power engineering amongst others. Working with the ANSYS suite of simulation products we are expert in its customisation for particular engineering applications. In addition we have recently developed cloud based hardware solutions for our client base which enables flexible, economic and on demand access to high end computing resources over the web. We have expertise in linear and nonlinear, static and dynamic, implicit and explicit, stress analyses, steady state and transient heat transfer analysis, computational fluid dynamics analysis, fluid-structure analysis.
Show more...Investment focus
- Industry: Medical Device, Medical, Construction
- Stage:Seed, Convertible Note
- Geography: Switzerland
Investor stats
- Total investments: 4
- Round size: Seed $2.7M–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FenX — FenX is a recyclable insulating product that turns mineral waste into usable resources to support a circular economy. Real estate developers, construction companies, and architects can now access non-flammable insulation materials for construction processes. the company's portfolio of recyclable insulation materials, which includes foamproducts and foam formulations made from readily available waste or natural materials with CO2 emissions.
- Citus — At CITUS we care about skin care. Explore the solutions we offer for your application
- Side Effects — EXPLAIN BETTER, SELL MORE WITH INTERACTIVE 3D von Side Effects Ag. The most powerful and easy-to-use software to create and share virtual 3D presentations, manuals, and trainings.
M2care specializes in transformative innovation to create more efficient, equitable, and long-term models.
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: France, Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- TheraSonic — TheraSonic aims to revolutionize the treatment of neurological diseases, particularly brain cancers.
- Rhovica Neuroimaging — Rhovica Neuroimaging is a rapid and safe placement of an external ventricular drain (EVD) and is a lifesaving emergency procedure. EVDs are thin catheters, that are inserted into the brain cavities (ventricles) for fluid drainage to decrease intracranial pressure (ICP) and for measurement of ICP.
Christian Wenger - Chairman @ Startup INVEST
Show more...Investment focus
- Industry: SaaS, Internet, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany, Australia
Investor stats
- Total investments: 7
- Round size: Seed $800k–$6.8M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- kollabo — Kollabo - the deep job platform for skilled blue collar workers. Thanks to our large network of temporary offices & our qualified team, we excel at finding the perfect match for job seekers and staffing agencies. Never before has the recruiting process been so easy and hassle-free for everyone involved. The goal is to digitally enable allstakeholder, generating a win-win-win situation. It can be that simple with Kollabo – We make work easy.
- ExpressSteuer — Rajazeus adalah link gacor dari provider slot deposit 5000 via qris terbaru gampang menang paling populer hari ini dikalangan warga +62.
Early stage deep-tech VC firm
Show more...Investment focus
- Industry: Health Care, Medical, Chemical
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, Belgium, Germany
Investor stats
- Total investments: 8
- Round size: Seed $1.2M–$7.7M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- ORamaVR — ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality.
- SolidWatts — We electrify industrial process heating by creating the new state-of-the-art in microwave and radio frequency power sources for industry.
- Anodyne Nanotech — Preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs.
Thanos Papangelis is the Co-Founder & Product Innovation Advisor at Epignosis.
Show more...Investment focus
- Industry: EdTech, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Switzerland, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ORamaVR — ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality.
- Morphoses — Live, expert-led group sessions that help children build confidence, improve communication, and develop strong social and emotional skills
Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the businesslifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 227
- Round size: Series A $3.2M–$31M; Series B $7.9M–$60M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $6.1M in 2011
Portfolio highlights
- XMOS — In 2005, a small team assembled to create a fast and flexible microcontroller that would enable designers to respond quickly to diversifying market demand. The first (XS1) and second (xcore-200) generation processors put unprecedented I/O capability (available through software for the first time) alongside significant DSP and controlprocessing – establishing XMOS as a name in the audio sector.The vision quickly shifted towards AI. Caught between two very different technical and commercial models, Graphcore was formed to focus on server-side AI, and XMOS continued the quest towards low-cost embedded intelligence (edge-AI). Most recently XMOS enabled voice to become mainstream, releasing the XVF3510 – a disruptive high-performance, low cost far-field 2-mic voice interface. This was followed up with xcore.ai – a new crossover processor for the AIoT that brings AI, DSP, control and I/O together in a single device.
- Focal Point Positioning — FocalPoint's software enables reliable GNSS in urban environments, mitigating multipath and enabling advanced vehicle autonomy.
- Mobile Travel Technologies — Mobile Travel Technologies (MTT) is the leading mobile travel technology specialist for airlines, hotels and travel intermediaries with an extensive customer base across the global travel industry.MTT’s advanced mobile travel platform powers some of the most successful and highest revenue generating mobile channels in the travel industry. As apioneer in this space having first launched mobile bookings for airlines in 2006, MTT has remained a first mover in mobile travel and has picked up many awards along the way for its successful, customer focused travel apps & mobile sites. MTT offers its clients unrivalled travel industry expertise, world-class mobile development, creative design, mobile usability expertise and a sophisticated mobile travel platform. MTT clients include Saudi Arabian Airlines (Saudia), the flag carrier for Kingdom of Saudi Arabia, LAN Airlines in Chile and TAM Airlines in Brazil (the LATAM Airlines Group), easyJet, transavia.com of the Air France KLM Group, Flybe, Jumeirah Group and Atlantis The Palm, Dubai.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dominik A. Lysek - Co-CSO @ vVardis
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 100% lead, 0% follow
Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Series E
- Geography: Switzerland
Investor stats
- Total investments: 6
- Round size: Series A $6.8M–$10M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PicoDRILL — PicoDRILL generates technology leadership for its partner/customers through cutting-edge technology for drilling needs in the nanotechnology field. picoDrill is a private company located in Lausanne, Switzerland.
- Diagnoplex — Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rüf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as wellas its high sensitivity and specificity.
- Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.
Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team
Show more...Investment focus
- Industry: Health Care, Hardware, Software
- Stage:Seed, Series A
- Geography: Switzerland, France
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Wyth — Wyth creates private digital spaces for virtual and hybrid audiences. With our fully customizable platform organizations can build a seamless experience and an online home for their communities to connect, learn, work, share and play without ever leaving Wyth. We give our customers full control over their brand experience, data ownership andbusiness relationships.
- Smeetz — Smeetz is the future of a unified, data-driven and dynamic pricing-oriented commerce for attractions and cultural venues.
- Avelo — Our mission is to save lives by bringing fast and actionable infectious disease diagnosis closer to the patient. Avelo's solution is a breath collection device. It works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Grant, Seed, Pre-Seed
- Geography: Spain, France, Germany
Investor stats
- Total investments: 187
- Lead/follow: no public data
Portfolio highlights
- Orfium — Find, use, track, and monetize music content across all channels with Orfium's industry-leading music rights management software.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
- Powerful Medical — Powerful Medical is a deep-tech company, tackling the most challenging problems of modern medicine using artificial intelligence and machine learning.
For more than 35 years, Nest, as the first ecological and ethical pension fund in Switzerland, has remained true to its guiding principle: the optimal provision for the companies affiliated with us and their employees.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Piomic — There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg andfoot ulcers.The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life. The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.By developing a therapy which is safe and effective we hope to set a better future for patients in need.
- Comphya — CaverSTIM is a novel implantable device able to restore natural penile erection by neuromodulation.
- Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
Steyn Group is a global single family office platform that specializes in private market investments. We provide infrastructure and zero time preference capital to support emerging investment managers and businesses.
Show more...Investment focus
- Industry: Advice, Hospital, CleanTech
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Switzerland, South Africa
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Bio-Logical — Bio-Logical offers technology to sequester carbon from agricultural waste and transform it into, climate resilience building fertiliser. This innovation is more than a product; it's a promise to regenerate land, dramatically boost crop yields, and tackle climate change head-on.
- Enko Education — [mk_page_section bg_image="https://enkoeducation.com/wp-content/uploads/2021/03/cnp-enko-399.jpg" blend_mode="darken" bg_position="center center" bg_repeat="no-repeat" bg_stretch="true" video_color_mask="#0a0a0a" video_opacity="0.3" min_height="0" pa...
- Carbon Capture Scotland — Carbon Capture Scotland seeks to get rid of carbon dioxide that has been organically stored in grains and barley.
Clement Benoit - Founder and CEO @ Fithouse
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United States, Spain
Investor stats
- Total investments: 29
- Lead/follow: no public data
Portfolio highlights
- AnFin — AnFin is a venture-backed fintech company building the most innovative products in the wealth management and brokerage space. We strongly believe in the power of the stock market to transform developing economies. Therefore, we want to democratize access to stocks, bonds, and structured investment products. By leveraging scalable technology andstrategic partnerships, AnFin plans to build an ecosystem of products that connect stakeholders in a seamless way.
- Cocunat — Cocunat is a natural and 100% toxic free cosmetics brand.
- Animoca Brands — Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security,and new business models.
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the …
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series C, Series A
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 39
- Lead/follow: no public data
Portfolio highlights
- MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
- Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
- Simulands — Human grade cardiovascular simulators
Supermoon Capital is a specialist platform helping visionary founders enhance our lives, organizations, and communities through healthy sleep.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical Device
- Stage:Seed, Series A
- Geography: Switzerland, United States, Israel
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
- Arcascope — We create mobile apps based in circadian science to help people sleep and feel better.
- Mosanna Therapeutics — Improving the lives of patients with metabolic obstructive sleep apnea using a transformative approach
AA Sons focuses on raising venture capital for ambitious, fast-growing companies with a desire to 'make the world a better place' in retail, mobility, healthcare, care, fintech and broader tech sectors.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: France, United States, Israel
Investor stats
- Total investments: 103
- Lead/follow: no public data
Portfolio highlights
- HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.
Medical Device Investor funding in Switzerland at a glance
Stats across 439 deals from 335 investors.
Access all 335 investors in Switzerland Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 335 investors investing in Switzerland Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!